Objectives Systemic lupus erythematosus (SLE) is a chronic multisystem genetically complex autoimmune disease characterised by the production of autoantibodies to nuclear and cellular antigens, tissue infl ammation and organ damage. Genome-wide association studies have shown that variants within the major histocompatibility complex (MHC) region on chromosome 6 confer the greatest genetic risk for SLE in European and Chinese populations. However, the causal variants remain elusive due to tight linkage disequilibrium across disease-associated MHC haplotypes, the highly polymorphic nature of many MHC genes and the heterogeneity of the SLE phenotype. Methods A high-density case-control single nucleotide polymorphism (SNP) study of the MHC region was undertaken in SLE cohorts of Spanish and Filipino ancestry using a custom Illumina chip in order to fi nemap association signals in these haplotypically diverse populations. In addition, comparative analyses were performed between these two datasets and a northern European UK SLE cohort. A total of 1433 cases and 1458 matched controls were examined. Results Using this transancestral SNP mapping approach, novel independent loci were identifi ed within the MHC region in UK, Spanish and Filipino patients with SLE with some evidence of interaction. These loci include HLA-DPB1, HLA-G and MSH5 which are independent of each other and HLA-DRB1 alleles. Furthermore, the established SLEassociated HLA-DRB1*15 signal was refi ned to an interval encompassing HLA-DRB1 and HLA-DQA1. Increased frequencies of MHC region risk alleles and haplotypes were found in the Filipino population compared with Europeans, suggesting that the greater disease burden in nonEuropean SLE may be due in part to this phenomenon. Conclusion These data highlight the usefulness of mapping disease susceptibility loci using a transancestral approach, particularly in a region as complex as the MHC, and offer a springboard for further fi ne-mapping, resequencing and transcriptomic analysis.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease characterised by the production of autoantibodies to nuclear and cellular antigens, tissue infl ammation and organ damage. There is a strong but complex genetic component to SLE susceptibility, whereby many polymorphisms each with a small or modest effect contribute to disease susceptibility. Genome-wide association studies have shown that variants within the major histocompatibility complex (MHC) region on chromosome 6 confer the greatest genetic risk for SLE in European and Chinese populations. [1] [2] [3] The extended MHC spans almost 8 Mb and is divided into fi ve subregions: extended class I (telomeric), class I, class III, class II and extended class II (centromeric). One of the most complex regions of the genome, this locus harbours two copy variable regions (the HLA-DRB genes in class II and the RCCX module containing complement component C4 in class III), some of the most polymorphic genes in the genome and conserved haplotypes where linkage disequilibrium (LD) extends over 2 Mb in some instances. The region has been the subject of extensive study given the importance of MHC alleles in the pathogenesis of tissue incompatibility, drug sensitivity, autoimmune, infectious and infl ammatory diseases.
In European SLE cohorts, well-established associations are observed with highly conserved and extended haplotypes bearing the class II alleles HLA-DRB1*03:01 and HLA-DRB1*15:01. 4 More recent high-density single nucleotide polymorphism (SNP) genotyping studies have demonstrated multiple independent signals across the MHC in northern European cohorts. 5 6 However, the causal variants remain elusive due to tight LD across disease-associated MHC haplotypes, the highly polymorphic nature of associated variants and the heterogeneity of the SLE phenotype. Fine-mapping studies across the MHC region in other European and non-European SLE populations are lacking. The haplotypic diversity consequent on differing ancestry and environment demonstrated by these populations at the MHC region as well as non-MHC loci should allow further refi nement of known association signals together with the identifi cation of novel susceptibility variants. Given these known haplotypic differences, we undertook a high-density case-control SNP study of the MHC region in SLE cohorts of Spanish and Filipino ancestry using ▶ Additional data are published online only. To view the fi les please visit the journal online (http://ard.bmj.com/ content/71/5.toc).
UK cohort
The cohort comprised 632 SLE probands and 742 unrelated controls from a previous study. 5 All SLE probands fulfi lled the American College of Rheumatology criteria for the classifi cation of SLE. 7 Written consent was obtained from all study participants.
Sample collection
DNA was obtained from whole blood using phenol-chloroform extraction. Native genomic DNA was used for the Spanish study. For the Filipino cohort, 100 ng (5 μl at 20 ng/μl) native DNA was whole genome amplifi ed using the Qiagen REPLI-g Midi Kit (Cat. No. 150045) according to the manufacturer's written instructions.
Custom iSelect Illumina SNP array and genotyping
The samples were genotyped at the Feinstein Institute, USA using a custom Illumina iSelect chip comprising 10 788 SNPs: 6045 SNPs within the MHC region (29-33.5 Mb) and 4743 SNPs informative for major and European ancestry (see online supplement for SNP selection criteria). 8 9 a custom Illumina chip in order to fi ne-map established association signals and potentially uncover novel susceptibility loci. In addition, we have performed comparative analyses between these two datasets and a northern European UK SLE cohort. In total we examined 1433 cases and 1458 matched controls.
METHODS

Spanish cohort
The cohort comprised 464 cases and 468 controls. All cases were recruited from rheumatology clinics throughout Spain. Control samples were obtained from the Blood Bank Units of the hospitals where the cases originated.
Filipino cohort
The cohort comprised 335 SLE probands and 247 unrelated controls. We also included 26 trios (father, mother and affected child) to allow checks for Mendelian inheritance. All probands attended the Rheumatology and Clinical Immunology Clinics at the University of Santo Tomas Hospital, Manila, Philippines. Unrelated controls were recruited from spouses and acquaintances of the probands.
Figure 1
High-density transancestral single nucleotide polymorphism (SNP) mapping of the major histocompatibility complex (MHC) region in UK, Spanish and Filipino systemic lupus erythematosus (SLE). The panels show MHC region association plots for (A) UK, (B) Spanish and (C) Filipino SLE cohorts where genomic position (Mb) is shown on the horizontal axis with -log 10 p values on the vertical axis. The black squares represent genotyped SNPs and the blue squares indicate imputed SNPs in the UK cohort. The red squares represent classically typed HLA alleles in the UK (HLA-DRB1 only) and Spanish (HLA-B, HLA-DRB1 and HLA-DQB1) cohorts. The panels beneath each association plot demonstrate the recombination rate for each cohort calculated using control haplotypes only generated with the program rhomap. 27 A scaled map of the MHC region with relevant genes is shown in the bottom panel. RCCX represents the copy variable RCCX module containing the complement C4 gene (R=RP1/STK19, C=C4A/C4B, C=CYP21A2/CYP21A1P, X=TNXA/TNXB).
were excluded if they were outliers on principal components analysis using post-QC AIMs (performed using EIGENSTRAT and defi ned as >4 SDs from the mean) 11 (failed Spanish n=62, Filipino n=88). The genomic infl ation factor (λ GC ) was calculated using the post-QC AIMs after correction for population stratification (Spanish λ GC =1.04 and Filipino λ GC =1.09).
UK SLE cohort imputation
Genotypes were imputed using IMPUTE 12 on the initial set of directly genotyped SNPs (n=1230) up to the Wellcome Trust Case-Control Consortium 2 (WTCCC2) study (n=7119). The WTCCC2 data were used as reference genotypes in the imputation, with dbsnp build 126 defi ning the genome map. 13 No reference haplotypes were used in the imputation. Of the 7119 imputed SNPs in the UK SLE cohort, 3314 overlapped with the 6045 MHC SNPs genotyped in the Spanish and Filipino cohorts in this study and were used for analysis.
Statistical analyses
Single marker association analyses using logistic regression and stepwise logistic regression analyses were performed using PLINK and SNPTEST. 14 We took the genotypes for the most associated SNP as a covariate and conditioned on this in the search for other independently associated SNPs in each dataset. If this analysis yielded further SNPs that passed our threshold of signifi cance (see below), we added the top SNP to further stepwise logistic regression models and continued the process until no further SNPs passed our threshold of signifi cance. Haplotypic association analyses were performed using PLINK and R statistical package. Data for SNP rs409558 in the Spanish and Filipino cohorts were meta-analysed using
HLA genotyping
All HLA typing was performed using Luminex One Lambda SSO. Four-digit genotyping for HLA-B, HLA-DRB1 and HLA-DQB1 was performed in 82%, 99% and 44% of the Spanish cohort, respectively, following quality control (QC) at Hospital Virgen del Rocío, Seville, Spain and Hospital Virgen de las Nieves, Granada, Spain.
In order to assess LD relationships, four-digit HLA-DRB1 typing was performed in a subset of the Filipino cohort of known genotype for the top SNP, rs9271366, where DNA was available (n=89). Four-digit HLA-DRB1 typing was performed in 606 of 632 UK cases of SLE (96%). The Filipino and UK typing was performed at the Anthony Nolan Trust, London, UK. Two-digit HLA-DRB1 data were obtained for 694 of the 742 UK controls (92%) from the 1958 British birth cohort.
Quality control (QC) fi lters
All QC analyses except principal components analyses were performed using PLINK. 10 Samples and SNPs were put forward for analysis if they met the following quality control fi lters: SNPs greater than 95% genotyping effi ciency, minor allele frequency (MAF) >1% (failed Spanish n=271, Filipino n=758), non-deviation from Hardy-Weinberg equilibrium in controls on the basis of a false discovery rate of 0.05 (failed Spanish n=61, Filipino n=21). SNPs were excluded if they showed >10% Mendel error rate in the post-QC Filipino trios (n=7). Samples required >95% genotyping effi ciency (failed Spanish n=50, Filipino n=50) and PI-Hat scores >0.2 on identity-by-descent analysis using ancestry informative markers (AIMs) in order to exclude cryptic relatedness and duplicate samples (failed Spanish n=27, Filipino n=3). In order to correct for population stratifi cation, samples −5 was set, given that genome-wide signifi cance thresholds based on haplotype structure are typically in the range of 5-7×10 −8 and that the MHC region constitutes approximately 1/1000th of the genome. The LD structure of the MHC region has been shown to be similar to that of the genome in general, but there appears to be greater LD between haplotype blocks in the MHC region so our signifi cance threshold is likely to be conservative. In the Spanish cohort, separate logistic regression and conditional logistic regression analyses were performed for HLA-DRB1 alleles in order to assess relative predispositional effects. In order to account for multiple testing, Bonferonni-corrected p values were used as follows: HLA-DRB1, p=0.0023 (0.05/22 alleles tested). We examined LD relationships between SNPs and HLA alleles in each cohort by calculating the correlation coeffi cient (r 2 ) using the Tagger algorithm in Haploview. 15 
RESULTS
In all three datasets under study there was signifi cant SNP association across the entire MHC region (fi gure 1). The UK SLE data confi rmed previously published reports in northern European cohorts demonstrating principal SNP association within the class II and class III regions of the MHC. 5 HLA-DRB1 typing in a subset of this cohort showed that the most highly associated SNP, rs9271366, was a perfect proxy for HLA-DRB1 
Major role for MHC class II and class I variants in Filipino SLE
Following QC measures, 275 cases and 166 controls were put forward for analysis in the Filipino SLE cohort. The overall pattern of association showed that, of the 3704 post-QC SNPs, the major signal arises from the class II region of the MHC and therefore differs from that observed in European SLE cohorts where principal associations are seen in class II and class III  (fi gure 1, table 1 and table S5 in that the greater disease burden in non-European SLE populations may be due in part to this phenomenon. Furthermore, the frequency of protective haplotypes in each population decreases through the same gradient (protective haplotype frequency cases 0.525, 0.505 and 0.005, respectively).
DISCUSSION
We present the results of the fi rst high-density transancestral mapping study of the MHC region in SLE using cohorts from the UK, Spain and the Philippines. Despite the modest sample sizes, we have identifi ed and replicated new independent loci with evidence of interaction across this complex region, some of which appear to be SLE-specifi c (MSH5) while others suggest shared mechanisms across autoimmune/infl ammatory diseases (HLA-DPB1, HLA-G, HLA-B/C) (box 1). In particular, we were able to demonstrate a considerable effect from MHC variants in Filipino SLE using single marker and haplotypic analyses due to the high frequency of disease-associated variants in this cohort. There are no accurate prevalence data for SLE in the Philippines and most parts of Asia, even in the most recent literature. In general, published prevalence rates for SLE in Asia are broadly similar to those observed in Europeans and range between 30 and 50 per 100 000. 22 24 26 Interestingly, prevalence rates appear to be higher in Asian migrant populations. 24 The primary class III risk haplotype tagged by rs1269852 and rs3130490 in Europeans displays extended LD such that it encompasses most of the MHC class III region. Stepwise logistic regression analyses demonstrated an identical protective haplotype encompassing the class III gene MSH5 alone in Filipino and Spanish SLE. These data suggest that dysregulation of MSH5 may underlie some of the risk attributable to the conserved class III risk haplotype. Further fi ne-mapping will be required to elucidate the nature of this signal. The class III variants that confer the greatest risk in SLE cohorts of European ancestry are rare in Filipino and Han Chinese SLE where MAF are approximately 0.001. These data suggest that either these variants are not important in SLE cohorts of south-east Asian ancestry or that different class III SNPs that are uncommon in Europeans and hence not typed in this study show association in these populations.
Two recent genome-wide association scans in SLE case-control cohorts of Chinese ancestry have shown that the most highly associated SNPs were located in the class II region of the MHC, between HLA-DRA and HLA-DQA2. 2 3 We observed a similar pattern of association in the Filipino cohort under study. The most highly associated SNP in the Filipino cohort, rs9271366, is a surrogate marker for HLA-DRB1*15:02. This SNP showed the greatest overall association in the Hong Kong Chinese genomewide association study and is ranked 8 of the top 13 MHC SNPs in the Han Chinese genome-wide association study in SLE, implicating HLA-DRB1*15:02 haplotypes in SLE susceptibility in these populations as well.
phenotype such as renal involvement, as is often observed in nonEuropean populations. [22] [23] [24] Refi nement of SLE-associated HLA-DRB1*15 signal Previous attempts to fi ne-map the SLE-associated HLA-DRB1*1501 haplotypic signal could only delimit the region to approximately 500 kb of the MHC class II region in EuropeanAmericans using microsatellite typing. 25 When the SNP rs9271366 was used as a surrogate marker for HLA-DRB1*15 haplotypes, we found that the LD surrounding this SNP varied in the different populations studied from a 375 kb region in UK SLE to a 182 kb region in Spanish SLE and to an 87 kb region encompassing HLA-DRB1 and the intergenic interval between HLA-DRB1 and HLA-DQA1 in Filipino SLE (fi gure 3). Hence, the transancestral mapping approach used in this study allowed refi nement of the SLE-associated HLA-DRB1*15 signal.
Evidence for genetic interaction between the top independent MHC region SNPs in SLE
Haplotypic analyses were performed on the top three independent SNPs from each cohort to look for evidence of interaction. The top SNP was chosen from each cohort, together with the next two independently associated SNPs which were selected following stepwise logistic regression (table 2) . Despite the relatively modest cohort sizes, these analyses suggested evidence of genetic interaction (non-additive effects) in all three populations studied (table S8 in online supplement). For example, in the Spanish cohort, a multiple logistic regression model was fi tted using the top three independent SNPs (rs3130490, rs3129768 and rs3117213) as explanatory variables and interaction terms were tested for. Interestingly, the best model (difference in Akaike Information Criterion=4.8, difference in Bayesian Information Criterion=6.8) had an rs3130490*rs3129768 interaction where the effect on the OR was positive (5.1 (95% CI 1.12 to 23.08), p=0.03), plus an independent additive term for rs3117213 (see table S9 and fi gure S4 in online supplement).
Increased frequency of MHC region risk alleles and haplotypes in Filipino SLE compared with European SLE
Next we examined haplotypic frequency and association using the top three independent SNPs in all three cohorts studied (table  2) . We found that the haplotype harbouring the risk alleles of the top three SNPs was rare in European SLE cohorts. However, in Filipino SLE, the risk haplotype was common while the protective haplotype was rare (risk OR 3.45, CI 2.24 to 5.33, p=5.69×10 −11 ; protective OR 0.002, CI 1×10 −4 to 0.05, p=2.10×10 −4 ). Thus, the population frequency of the top ranked risk alleles and risk haplotypes increases from the UK and Spain to the Philippines (risk haplotype frequency cases 0, 0.004 and 0.273, respectively), suggesting SLE. These signals are independent of each other and HLA-DRB1 alleles and show some evidence of genetic interaction. These data highlight the usefulness of mapping disease susceptibility loci using a transancestral approach, particularly in a region as complex as the MHC, and offer a springboard for further fi nemapping, resequencing and transcriptomic analysis.
Using transancestral SNP mapping of the MHC region in SLE, we have successfully refi ned the established SLE-associated HLA-DRB1*15 signal to an interval encompassing HLA-DRB1 and HLA-DQA1. We have identifi ed and replicated association in the genes MSH5 and HLA-DPB1 in Filipino and Spanish SLE cohorts, and also demonstrated association at HLA-G in Filipino Box 1 Major histocompatibility complex region susceptibility genes and haplotypes in systemic lupus erythematosus ▶ HLA-DPB1: For the fi rst time we report an association with single nucleotide polymorphisms (SNPs) in the region of HLA-DPB1 and systemic lupus erythematosus (SLE). The most associated SNP in this region is rs3117213, located between the pseudogenes HLA-DPA2 and COL11A2P. This SNP has previously shown association with ACPA-positive rheumatoid arthritis (RA) in northern European cohorts and is independent of the known RA HLA-DRB1 risk alleles. 29 30 The association of HLA-DPB1 alleles with chronic beryllium disease is well established. 31 Recent studies have also detected associations in the HLA-DPB1 region with chronic hepatitis B infection, Wegener's granulomatosis, primary biliary cirrhosis, Graves' disease, Takayasu's arteritis, juvenile idiopathic arthritis, systemic sclerosis and multiple sclerosis in European and non-European populations. 29 32-36 The association of this region with these autoimmune, infectious and infl ammatory diseases suggests that it is likely to represent a shared autoimmune/infl ammatory locus. 43 Haplotypes harbouring HLA-DRB1*15:01 alleles confer risk for SLE and multiple sclerosis but also demonstrate protection in diseases such as type 1 diabetes and IgA defi ciency. 4 5 The mechanisms underlying these phenomena are unknown. ▶ HLA-C / HLA-B region: Data from the Filipino and UK SLE cohorts under study reveal association in the class I region of the MHC encompassing HLA-C/HLA-B/MICA. A recent genome-wide association study comparing HIV-1 controllers and progressors found that the same region harbours the major genetic determinants of HIV-1 control. Further analysis implicated specifi c HLA-B allele peptide groove amino acids, in addition to an independent HLA-C effect in the control of HIV infection. 44 
